Mandate

Millimed Holdings acquires Cube Medical

May 12, 2005

Millimed Holdings Inc., a newly established US holding company backed by ten Danish and international venture investment funds fronted by Advent International, has agreed to acquire Cube Medical A/S, a Denmark based research, development and production company within the area of vascular medical devices, and Millimed Vascular Intervention AB, a Sweden based sales and marketing company for vascular medical devices. The initial consideration of is USD 12m and an investment of USD 10m contingent upon the achievement of certain milestones.

Vinge acted for Millimed Holdings Inc.
Arne Källén (responsible partner)
Anna Jonsson (associate)

Related

Vinge has advised Vitamin Well and its majority shareholders Cinven, Bridgepoint and the founders on Vitamin Well's combination with EMPWR

Vinge has advised Vitamin Well and its majority shareholders Cinven, the founders of Vitamin Well and Bridgepoint on Vitamin Well's acquisition of EMPWR Nutrition Group from majority seller Waterland Private Equity Investments.
July 03, 2026

Vinge has advised Morrow Bank in connection with its issuances of primary capital instruments (AT1) and tier 2 capital bonds (T2)

The issuances comprised perpetual AT1 bonds of NOK 300 million with a floating coupon of 3-month NIBOR + 425 basis points and a first call date in 2031, as well as subordinated Tier 2 bonds of SEK 200 million with a floating coupon of 3-month STIBOR + 325 basis points and a first call date in 2031. The bonds are intended to be admitted to trading on Nasdaq Stockholm.
July 03, 2026

Vinge advises Wihlborgs Fastigheter in connection with the financing of property acquisition valued at SEK 13.3 billion

Vinge advises Wihlborgs Fastigheter AB (publ) in connection with the financing of the acquisition of all of Castellum’s property holdings in Malmö, Lund and Helsingborg. The financing has been secured through Danske Bank, SEB and Swedbank.
June 29, 2026